Intevac Announces Fourth Quarter and Full Year 2015 Financial Results
Wed, February 3 2016
Highlights for Fiscal 2015:
- Revenues at the high end of guidance, up 15% from 2014
- Gross margin improved 842bp, compared to 2014
- Orders up 43% from 2014 – reflecting 40% and 47% increases in Thin-Film Equipment and Photonics, respectively
- Achieved sign-off on first VERTEX™ system for display cover panel; received order on second system from a new Tier 1 customer
- Achieved sign-off on first MATRIX™ PVD system for solar; received order on second system from a new Tier 1 customer
- Passed key milestones of joint development program and received first MATRIX implant order from Tier 1 solar customer
- Multiple contract awards in Photonics, and $25 million funding vehicle in place for next-generation sensor development
- Upgrades, spares and services for the hard disk drive industry up over 130% from 2014
-
Executed
$18 .5 million in stock repurchases, bringing the cumulative total to$28 .5 million at year-end out of a $30 million plan
“2015 was a year of execution on our strategic growth initiatives; and
we made significant progress on all fronts,” commented
($ Millions, except per share amounts) | Q4 2015 | Q4 2014 | ||||||||||||||||||
Non-GAAP |
||||||||||||||||||||
GAAP Results |
Results |
GAAP Results | Non-GAAP Results | |||||||||||||||||
Net Revenues | $ | 16.4 | $ | 16.4 | $ | 19.1 | $ | 19.1 | ||||||||||||
Operating Loss | $ | (2.3 | ) | $ | (2.2 | ) | $ | (5.3 | ) | $ | (5.6 | ) | ||||||||
Net Loss | $ | (2.5 | ) | $ | (2.4 | ) | $ | (14.4 | ) | $ | (5.2 | ) | ||||||||
Net Loss per Share | $ | (0.12 | ) | $ | (0.12 | ) | $ | (0.62 | ) | $ | (0.23 | ) | ||||||||
|
Year Ended | Year Ended | ||||||||||||||||||
|
|
|||||||||||||||||||
Non-GAAP | ||||||||||||||||||||
GAAP Results |
Results |
GAAP Results | Non-GAAP Results | |||||||||||||||||
Net Revenues | $ | 75.2 | $ | 75.2 | $ | 65.6 | $ | 65.6 | ||||||||||||
Operating Loss | $ | (8.7 | ) | $ | (8.8 | ) | $ | (19.4 | ) | $ | (19.3 | ) | ||||||||
Net Loss | $ | (9.2 | ) | $ | (9.3 | ) | $ | (27.4 | ) | $ | (18.0 | ) | ||||||||
Net Loss per Share | $ | (0.41 | ) | $ | (0.42 | ) | $ | (1.16 | ) | $ | (0.76 | ) | ||||||||
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; (2) restructuring charges and (3) deferred tax asset valuation allowance. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section. |
||||||||||||||||||||
Fourth Quarter Fiscal 2015 Summary
The net loss for the quarter was
Revenues were
Thin-film Equipment gross margin was 41.8% compared to (20.1)% in the
fourth quarter of 2014 and 17.8% in the third quarter of 2015. The
improvement from the fourth quarter of 2014 and the third quarter of
2015 reflected a higher mix of higher-margin upgrades and improved
factory absorption. Thin-film Equipment gross margin in the fourth
quarter of 2014 reflected a
Photonics gross margin was 39.6% compared to 44.4% in the fourth quarter of 2014 and 35.5% in the third quarter of 2015. The decline from the fourth quarter of 2014 was due to lower margins on technology development contracts and higher factory overhead due to the modified cost structure implemented in the second quarter of 2015. The improvement from the third quarter of 2015 was primarily due to improved sensor yields, offset in part by lower margins on technology development contracts. Consolidated gross margin was 40.7%, compared to 13.6% in the fourth quarter of 2014 and 26.7% in the third quarter of 2015.
R&D and SG&A expenses were
Order backlog totaled
The company ended the year with
The company repurchased 1.5 million shares of common stock for a total
of
Fiscal Year 2015 Summary
The net loss was
Revenues were
Thin-film Equipment gross margin was 32.4%, compared to 0.7% in 2014.
The improvement from 2014 reflected a higher level of revenue and
improved factory absorption. Thin-film Equipment gross margin in 2014
reflected a
R&D and SG&A expenses were
The company repurchased 3.4 million shares of common stock for a total
of
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The company will discuss its financial results and outlook in a
conference call today at 1:30 p.m. PST (4:30 p.m. EST). To participate
in the teleconference, please call toll-free (877) 334-0811 prior to the
start time. For international callers, the dial-in number is
(408) 427-3734. You may also listen live via the
About
In our Thin-Film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the company's website at www.intevac.com.
200 Lean® is a registered trademark and
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
|
||||||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||||||
(Unaudited, in thousands, except percentages and per share amounts) |
||||||||||||||||||||
Three months ended |
|
Year ended |
||||||||||||||||||
|
|
|
|
|||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||
Net revenues | ||||||||||||||||||||
Thin-film Equipment | $ | 8,308 | $ | 9,106 | $ | 39,622 | $ | 25,290 | ||||||||||||
Photonics | 8,090 | 9,956 | 35,538 | 40,260 | ||||||||||||||||
Total net revenues | 16,398 | 19,062 | 75,160 | 65,550 | ||||||||||||||||
Gross profit | 6,677 | 2,596 | 26,317 | 17,433 | ||||||||||||||||
Gross margin | ||||||||||||||||||||
Thin-film Equipment | 41.8 | % | (20.1 | )% | 32.4 | % | 0.7 | % | ||||||||||||
Photonics | 39.6 | % | 44.4 | % | 37.9 | % | 42.9 | % | ||||||||||||
Consolidated | 40.7 | % | 13.6 | % | 35.0 | % | 26.6 | % | ||||||||||||
Operating expenses | ||||||||||||||||||||
Research and development | 4,150 | 3,015 | 15,661 | 15,832 | ||||||||||||||||
Selling, general and administrative | 4,723 | 5,150 | 19,638 | 21,205 | ||||||||||||||||
Acquisition-related1 | 106 | (269 | ) | (244 | ) | (250 | ) | |||||||||||||
Total operating expenses | 8,979 | 7,896 | 35,055 | 36,787 | ||||||||||||||||
Total operating loss | (2,302 | ) | (5,300 | ) | (8,738 | ) | (19,354 | ) | ||||||||||||
Operating income (loss) | ||||||||||||||||||||
Thin-film Equipment | (2,119 | ) | (6,327 | ) | (9,345 | ) | (22,008 | ) | ||||||||||||
Photonics | 1,146 | 2,336 | 5,206 | 8,932 | ||||||||||||||||
Corporate | (1,329 | ) | (1,309 | ) | (4,599 | ) | (6,278 | ) | ||||||||||||
Total operating loss | (2,302 | ) | (5,300 | ) | (8,738 | ) | (19,354 | ) | ||||||||||||
Interest income and other income (expense), net | 39 | 32 | 127 | 337 | ||||||||||||||||
Loss before income taxes | (2,263 | ) | (5,268 | ) | (8,611 | ) | (19,017 | ) | ||||||||||||
Provision for income taxes | 263 | 9,090 | 555 | 8,428 | ||||||||||||||||
Net loss | $ | (2,526 | ) | $ | (14,358 | ) | $ | (9,166 | ) | $ | (27,445 | ) | ||||||||
Loss per share | ||||||||||||||||||||
Basic and Diluted | $ | (0.12 | ) | $ | (0.62 | ) | $ | (0.41 | ) | $ | (1.16 | ) | ||||||||
Weighted average common shares outstanding | ||||||||||||||||||||
Basic and Diluted | 21,010 | 23,243 | 22,218 | 23,671 | ||||||||||||||||
1Amounts for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
||||||||||||||||||||
|
||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||
(In thousands, except par value) |
||||||||||
|
|
|||||||||
2016 | 2015 | |||||||||
(Unaudited) |
(see Note) |
|||||||||
ASSETS | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short-term investments | $ | 36,954 | $ | 51,080 | ||||||
Accounts receivable, net | 12,310 | 12,087 | ||||||||
Inventories | 18,760 | 19,212 | ||||||||
Prepaid expenses and other current assets | 1,712 | 1,727 | ||||||||
Total current assets |
69,736 | 84,106 | ||||||||
Long-term investments | 9,673 | 17,542 | ||||||||
Restricted cash | 1,780 | 1,780 | ||||||||
Property, plant and equipment, net | 11,921 | 12,826 | ||||||||
Intangible assets, net | 3,112 | 3,966 | ||||||||
Deferred income tax and other long-term assets | 1,459 |
|
55 | |||||||
Total assets | $ | 97,681 | $ | 120,275 | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||
Current liabilities | ||||||||||
Accounts payable | $ | 5,950 | $ | 4,640 | ||||||
Accrued payroll and related liabilities | 4,066 | 3,977 | ||||||||
Other accrued liabilities | 5,632 | 8,277 | ||||||||
Customer advances | 3,625 | 2,551 | ||||||||
Total current liabilities | 19,273 | 19,445 | ||||||||
Other long-term liabilities | 2,411 | 2,200 | ||||||||
Stockholders’ equity | ||||||||||
Common stock ( |
20 | 23 | ||||||||
Additional paid-in capital | 166,514 | 161,271 | ||||||||
|
(28,489 | ) | (9,989 | ) | ||||||
Accumulated other comprehensive income | 412 | 619 | ||||||||
Accumulated deficit | (62,460 | ) | (53,294 | ) | ||||||
Total stockholders’ equity | 75,997 | 98,630 | ||||||||
Total liabilities and stockholders’ equity | $ | 97,681 | $ | 120,275 | ||||||
Note: Amounts as of |
||||||||||
|
||||||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS |
||||||||||||||||||||
(Unaudited, in thousands, except per share amounts) |
||||||||||||||||||||
Three months ended |
|
Year ended |
||||||||||||||||||
|
|
|
|
|||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||
Non-GAAP Loss from Operations | ||||||||||||||||||||
Reported operating loss (GAAP basis) | $ | (2,302 | ) | $ | (5,300 | ) | $ | (8,738 | ) | $ | (19,354 | ) | ||||||||
Change in fair value of contingent consideration obligations1 | 106 | (269 | ) | (244 | ) | (250 | ) | |||||||||||||
Restructuring charges2 | — | — | 148 | 288 | ||||||||||||||||
Non-GAAP Operating Loss | $ | (2,196 | ) | $ | (5,569 | ) | $ | (8,834 | ) | $ | (19,316 | ) | ||||||||
Non-GAAP Net Loss | ||||||||||||||||||||
Reported net loss (GAAP basis) | $ | (2,526 | ) | $ | (14,358 | ) | $ | (9,166 | ) | $ | (27,445 | ) | ||||||||
Change in fair value of contingent consideration obligations1 | 106 | (269 | ) | (244 | ) | (250 | ) | |||||||||||||
Restructuring charges2 | — | — | 148 | 288 | ||||||||||||||||
Valuation allowance on deferred tax assets3 | — | 9,394 | — | 9,394 | ||||||||||||||||
Income tax effect of non-GAAP adjustments4 | — | — | — | — | ||||||||||||||||
Non-GAAP Net Loss | $ | (2,420 | ) | $ | (5,233 | ) | $ | (9,262 | ) | $ | (18,013 | ) | ||||||||
Non-GAAP Loss Per Diluted Share | ||||||||||||||||||||
Reported loss per diluted share (GAAP basis) | $ | (0.12 | ) | $ | (0.62 | ) | $ | (0.41 | ) | $ | (1.16 | ) | ||||||||
Change in fair value of contingent consideration obligations1 | 0.01 | (0.01 | ) | (0.01 | ) | (0.01 | ) | |||||||||||||
Restructuring charges2 | — | — | 0.01 | 0.01 | ||||||||||||||||
Valuation allowance on deferred tax assets3 | — | 0.40 | — | 0.40 | ||||||||||||||||
Non-GAAP Loss Per Diluted Share | $ | (0.12 | ) | $ | (0.23 | ) | $ | (0.42 | ) | $ | (0.76 | ) | ||||||||
Weighted average number of diluted shares | 21,010 | 23,243 | 22,218 | 23,671 | ||||||||||||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
||||||||||||||||||||
2Results for all periods presented include severance and other employee-related costs related to various restructuring programs. |
||||||||||||||||||||
3In accordance with ASC Topic 740, Income Taxes, the
company determined based upon an evaluation of all available
objectively verifiable evidence, including but not limited to the
company’s |
||||||||||||||||||||
4The amount represents the estimated income tax effect of the non-GAAP adjustments. The company calculated the tax effect of non-GAAP adjustments by applying an applicable estimated jurisdictional tax rate to each specific non- GAAP item. |
View source version on businesswire.com: http://www.businesswire.com/news/home/20160203005550/en/
Chief Financial Officer
or
Investor Relations
Source: